Asia-Pacific Prebiotics for Infant Formula Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

What is the Asia-Pacific Prebiotics for Infant Formula Market Size and Growth Rate?

• The Asia-Pacific prebiotics for infant formula market size was valued at USD 467.47 million in 2024 and is expected to reach USD 809.22 million by 2032, at a CAGR of 7.10% during the forecast period
• Market expansion is primarily driven by increasing awareness among parents about infant gut health and the importance of prebiotics in mimicking the functional benefits of human milk oligosaccharides (HMOs)
• In addition, growing demand for premium infant nutrition products, combined with rising disposable incomes and increased female workforce participation, is significantly propelling market growth across emerging economies in the region

What are the Major Takeaways of Prebiotics for Infant Formula Market?

• Prebiotics for Infant Formula, particularly those containing galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS), are gaining traction for promoting healthy gut microbiota, boosting immunity, and supporting overall infant health
• Market demand is largely driven by the shift toward functional and fortified baby food, increased penetration of international infant formula brands, and greater healthcare professional endorsements for prebiotic inclusion
• The growing preference for close-to-breastmilk substitutes and increasing focus on pediatric nutrition innovation are expected to further accelerate the adoption of prebiotic-enriched infant formulas in Asia-Pacific
• Japan dominated the Asia-Pacific prebiotics for infant formula market in 2024, accounting for the largest revenue share of 54.89%, driven by strong parental preference for high-quality, science-backed infant nutrition
• China is projected to be the fastest-growing market with the highest CAGR of 8.66% in Asia-Pacific from 2025 to 2032, propelled by a large infant population, rising disposable income, and a shift toward premium infant nutrition
• The Human Milk Oligosaccharides (HMOs) segment dominated the market with the largest revenue share of 36.4% in 2024, owing to their close resemblance to naturally occurring prebiotics found in breast milk

Report Scope and Prebiotics for Infant Formula Market Segmentation        

What is the Key Trend in the Prebiotics for Infant Formula Market?

“Innovation in Human Milk Oligosaccharide (HMO) Integration”

• A prominent trend in the Asia-Pacific prebiotics for infant formula market is the increasing inclusion of Human Milk Oligosaccharides (HMOs), which closely mimic the beneficial prebiotics found in natural breast milk. HMOs support gut health, immunity, and cognitive development in infants, making them a key focus area for premium formula brands
  • For instance, Abbott Laboratories has introduced formulas containing 2’-FL HMO under its Similac brand in Asia-Pacific markets, aimed at replicating the natural benefits of breast milk for non-breastfed infants
• Market players are investing in biotechnology-driven fermentation processes to produce HMOs at scale. Companies such as DSM and FrieslandCampina Ingredients are collaborating with local brands to expand HMO-based offerings in countries such as China, Japan, and India
• The surge in research linking HMOs to stronger immune responses and long-term infant health is driving increased parental preference for formulas that offer similar nutritional advantages to breastfeeding
• As scientific advancements continue, the integration of multiple HMOs and customization of prebiotic blends are expected to become a central differentiator in product innovation, further shaping consumer demand in the region

What are the Key Drivers of Prebiotics for Infant Formula Market?

• Rising awareness about infant gut microbiome development and the benefits of prebiotics in replicating breast milk’s health effects is a major growth driver
  • For instance, in June 2024, Danone launched an advanced formula range enriched with GOS and FOS prebiotics in China, aimed at boosting immunity and digestion in infants
• The market is also driven by growing urbanization and lifestyle shifts, leading to increased reliance on infant formula, especially among working mothers in emerging economies such as India, Indonesia, and Vietnam
• In addition, the region is witnessing strong government and pediatric support for fortified nutrition to address early childhood development concerns, further accelerating demand for high-quality prebiotic-enriched formulas
• Rapid expansion of e-commerce platforms and growing availability of global brands through online channels is improving product accessibility and fueling cross-border demand

Which Factor is challenging the Growth of the Prebiotics for Infant Formula Market?

• One of the primary challenges is high product cost, especially for prebiotic-enriched and HMO-based infant formulas, which limits affordability for a large segment of price-sensitive consumers
  • For instance, while premium brands such as Nestlé’s NAN Supreme offer advanced prebiotic blends, their price points are often out of reach for rural and lower-income households in countries such as India and the Philippines
• In addition, stringent regulatory approvals and varying standards across countries can delay product launches and increase costs for manufacturers seeking to expand regionally
• There is also a persistent lack of awareness about the specific health benefits of prebiotics compared to basic formula options, particularly in underdeveloped markets where education on early nutrition remains limited
• Overcoming these challenges through localized pricing strategies, wider healthcare education campaigns, and collaborative efforts with governments and NGOs will be key to unlocking long-term market growth

How is the Prebiotics for Infant Formula Market Segmented?

The market is segmented on the basis of type, source, grade, form, product type, and infant age.

• By Type

On the basis of type, the Asia-Pacific prebiotics for infant formula market is segmented into Human Milk Oligosaccharides (HMOs), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), and Inulin. The Human Milk Oligosaccharides (HMOs) segment dominated the market with the largest revenue share of 36.4% in 2024, owing to their close resemblance to naturally occurring prebiotics found in breast milk. HMOs support gut health, immune function, and cognitive development, driving their inclusion in high-end and premium infant formulas.

The Galactooligosaccharides (GOS) segment is expected to witness the fastest growth rate from 2025 to 2032, driven by increasing consumer awareness of gut microbiota benefits and the rising availability of GOS-fortified formulas at affordable price points.

• By Source

On the basis of source, the market is segmented into Bacteria, Algae, Fungi, and Plants & Vegetables. The Plants & Vegetables segment held the largest market revenue share in 2024, accounting for 41.8%, due to the wide availability, cost-effectiveness, and natural origin of plant-based prebiotics such as inulin and FOS. Manufacturers are leveraging plant-derived ingredients to appeal to health-conscious and sustainability-focused consumers.

The Bacteria segment is expected to exhibit the fastest CAGR from 2025 to 2032, as technological advancements in fermentation processes enable efficient production of complex prebiotics such as HMOs and GOS with bacterial strains.

• By Grade

On the basis of grade, the market is segmented into Inorganic and Organic. The Inorganic segment dominated the market in 2024 with a revenue share of 58.3%, attributed to its affordability, higher availability, and widespread application in conventional infant formula products.

The Organic segment is anticipated to grow at the fastest pace from 2025 to 2032, driven by increasing demand for clean-label, chemical-free baby nutrition and regulatory support for organic certifications across Asia-Pacific markets.

• By Form

On the basis of form, the market is segmented into Powder and Liquid. The Powder segment accounted for the largest market share of 67.1% in 2024, owing to its longer shelf life, ease of transport, and wide usage across both retail and institutional sales.

The Liquid segment is expected to register the highest growth rate during the forecast period due to rising consumer preference for ready-to-feed (RTF) formulas, particularly in urban areas where convenience and time-saving are valued.

• By Product Type

On the basis of product type, the market is segmented into Standard Formula, Toddler Formula, Follow-Up Formula, and Special Formula. The Standard Formula segment led the market with a dominant share of 40.6% in 2024, driven by its widespread use among infants aged 0–6 months and broad availability through both domestic and international brands.

The Special Formula segment is expected to experience the fastest CAGR from 2025 to 2032, spurred by rising awareness of infant allergies, digestive disorders, and specialized nutritional needs requiring tailored formulations.

• By Infant Age

On the basis of infant age, the market is segmented into 0–6 Months, 6–12 Months, and 1–3 Years. The 0–6 Months age group dominated the market in 2024 with a revenue share of 49.7%, supported by higher dependency on formula feeding in the early postnatal phase, especially among working mothers and in urban households.

The 1–3 Years age segment is projected to grow at the fastest rate, driven by the increasing trend of nutritional supplementation in toddlers to support cognitive and physical development post-weaning.

Which Region Holds the Largest Share of the Prebiotics for Infant Formula Market?

• Japan dominated the Asia-Pacific prebiotics for infant formula market in 2024, accounting for the largest revenue share of 54.89%, driven by strong parental preference for high-quality, science-backed infant nutrition
• With a declining birth rate but high per capita spending on infant health, Japanese consumers prefer premium formulas enriched with HMOs, GOS, and FOS
• The country’s stringent food safety standards, along with innovation in organic and functional formulations, support sustained market leadership

China Prebiotics for Infant Formula Market Insight

China is projected to be the fastest-growing market with the highest CAGR of 8.66% in Asia-Pacific from 2025 to 2032, propelled by a large infant population, rising disposable income, and a shift toward premium infant nutrition. Chinese parents are increasingly aware of gut health and immunity benefits linked to prebiotics such as FOS, MOS, and PDX, driving strong demand across urban and Tier II/III cities. Domestic brands are expanding rapidly, supported by favorable policies and booming e-commerce, making prebiotic-rich infant formulas widely accessible.

India Prebiotics for Infant Formula Market Insight

India is witnessing steady growth in the prebiotics for infant formula market, driven by rising awareness of infant nutrition and a growing middle-class population. Improved healthcare access, higher disposable income, and an increasing number of working mothers are supporting demand for infant formula enriched with inulin, GOS, and PDX. While regulatory approvals and affordability remain challenges, urbanization and retail penetration are enhancing the availability of premium formula options across metros and Tier I cities.

Australia Prebiotics for Infant Formula Market Insight

Australia holds a significant share of the Asia-Pacific prebiotics for infant formula market, supported by a well-established regulatory environment and high consumer trust in nutritional science. Australian parents are early adopters of advanced infant formulas containing HMOs and organic prebiotics, favoring clean-label, traceable ingredients. The country also plays a major role in exporting premium prebiotic-enriched formulas to neighboring Asia-Pacific markets, further strengthening its regional influence.

Southeast Asia Prebiotics for Infant Formula Market Insight

Southeast Asia is emerging as a high-potential market for Prebiotics for Infant Formula, led by countries such as Indonesia, Vietnam, and Thailand. Increasing urbanization, rising health literacy, and expanding retail infrastructure are driving the adoption of formulas fortified with GOS, FOS, and lactulose. The region benefits from local production expansions and strategic partnerships with global brands, aiming to address both affordability and nutritional needs of growing infant populations.

Which are the Top Companies in Prebiotics for Infant Formula Market?

The prebiotics for infant formula industry is primarily led by well-established companies, including:

• Jennewein Biotechnologie GmbH (Germany)
• zuChem Inc. (U.S.)
• Biosynth Carbosynth (Switzerland)
• ELICITYL SA (France)
• Dextra Laboratories Limited (U.K.)
• Glycom A/S (Denmark)
• Tereos (France)
• Ingredion Incorporated (U.S.)
• Royal FrieslandCampina N.V. (Netherlands)
• Südzucker AG (Germany)
• Cargill, Incorporated (U.S.)
• Fonterra Co-operative Group (New Zealand)
• Royal Cosun (Netherlands)
• COSUCRA (Belgium)
• New Francisco (Yunfu City) Biotechnology Corporation Limited (China)
• Dana Dairy Group (Switzerland)
• Glycosyn LLC (U.S.)
• DuPont (U.S.)

What are the Recent Developments in Asia-Pacific Prebiotics for Infant Formula Market?

• In September 2024, Samyang Corporation held a groundbreaking ceremony for its new Specialty Plant in Ulsan, committing approximately USD 105 million to the project. The facility will house South Korea’s largest allulose production plant with an annual capacity of 13,000 tons, alongside a prebiotics production unit manufacturing resistant dextrin and fructo-oligosaccharide powder. This expansion marks a strategic move by Samyang to enhance its footprint in North America, Japan, and Southeast Asia’s health-oriented ingredient markets
• In January 2024, the biotics sector experienced several key updates, including progress toward establishing postbiotic standards in China and rising demands for stricter probiotic regulations in Hong Kong. These developments highlight the growing need for regulatory clarity and quality control within the global biotics industry
• In November 2023, Ting Li Development, the investment arm of Ting Hsin International Group which commands nearly 35% of China’s instant food and beverage market—entered a strategic alliance focused on reducing sugar and carbohydrate levels in its product portfolio. This collaboration reflects the increasing industry emphasis on health-conscious formulations in the Asian F&B sector
• In June 2023, Sanofi partnered with AB-BIOTICS to launch a line of probiotics aimed at improving cholesterol levels for consumers in South Korea. This initiative underscores the role of functional supplements in addressing prevalent health concerns in the Asian market

SKU-51828